Synthesis and receptor binding studies of novel 4,4-disubstituted arylalkyl/arylalkylsulfonyl piperazine and piperidine-based derivatives as a new class of σ1 ligands
摘要:
This study presents the synthesis and biological evaluation of a new series of arylalkyliary/alkylsulfonyl piperazine and piperidine-based derivatives as sigma receptor ligands. It was found that a number of halogen substituted sulfonamides display relatively high and low affinities to sigma(1) and sigma(2) receptors, respectively. The sigma(1) affinities and subtype selectivities of four piperidine derivatives were also found to be generally comparable to those of piperazine analogues. Compared to sigma(1)-Rs compounds with n = 0 and 2, those with n = 1 proved to have optimal length of carbon chain by exhibiting higher affinities.Within this series, the 4-benzyl-1-(3-iodobenzylsulfonyl)piperidine sigma ligand was identified with 96-fold sigma(1)/sigma(2) selectivity ratio (K-i sigma(i) = 0.96 +/- 0.05 nM and K-i sigma(2) = 91.8 +/- 8.1 nM). (C) 2013 Elsevier Masson SAS. All rights reserved.
[EN] COMPOUND FOR REGULATING GENE EDITING EFFICIENCY AND APPLICATION THEREOF<br/>[FR] COMPOSÉ DESTINÉ À RÉGULER L'EFFICACITÉ D'ÉDITION DE GÈNE ET SON APPLICATION<br/>[ZH] 用于调控基因编辑效率的化合物及其应用
COMPOUND FOR REGULATING GENE EDITING EFFICIENCY AND APPLICATION THEREOF
申请人:Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences
公开号:US20210207175A1
公开(公告)日:2021-07-08
A compound for improving the gene editing specificity and application thereof. Specifically disclosed is a compound represented by formula I or a use of a pharmaceutically acceptable salt thereof. The compound and the pharmaceutically acceptable salt thereof are used for preparing an inhibitor, a composition, or a formulation for inhibiting gene editing and/or improving the gene editing specificity. The structure of the formula I is as stated in the description. The compound can significantly improve the accuracy of CRISPR gene editing, thereby providing a simple and high-efficient policy for accurate gene editing.